Atara stock plunges 41% upon the FDA issuance of a CRL against its BLA for Ebvallo to treat EBV+ PTLD. The company is also facing a severe cash crunch.

Tabelecleucel, an allogeneic, EBV-specific T-cell immunotherapy, works by targeting and eliminating EBV-infected cells.

The FDA has issued a complete response letter to the biologics license application seeking the approval of tabelecleucel for ...

On the third day, drugmakers provided updates on precision medicines for cancer and Alzheimer's, and Grail talked about the launch of a new version of the Galleri test.

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/17.DwxO7Jta.js ...

Shares of Atara Biotherapeutics, Inc. (NASDAQ:ATRA) tumbled 51% after the company disclosed receiving a Complete Response ...

Investing.com -- Atara Biotherapeutics, Inc. (NASDAQ:ATRA)股价暴跌51%，此前该公司披露收到美国食品和药物管理局（FDA）就其EBVALLOTM（tabelecleucel）治疗发出的完整回复函（CRL）。这份CRL涉及用于某些Epstein-Barr病毒阳性移植后淋巴增殖性疾病（EBV+ ...

Older people who regularly drink green tea have fewer brain lesions are characteristic of dementia than those who do not ...

As per NPJ - Science of Food, participants who drank 600 ml of green tea as compared to a consumption level of 200 ml had 3% less brain damage.

Research led by the Kanazawa University Graduate School of Medical Sciences has reported a significant connection between ...

A cutting-edge AI tool can now predict how well seed potatoes will grow into healthy potato plants. Developed by biologists ...

The current human tissue-based study provides convincing evidence correlating hippocampal expressions of RNA guanine-rich G-quadruplexes with aging and with Alzheimer's Disease presence and severity.